fda covid vaccine - Search News

Order byBest matchMost fresh

FDA Will Approve COVID-19 Vaccine

FDA picks a new strain for fall Covid vaccines. Here's what it means for your next shot.

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most at-risk Americans this fall.

· 4h · on MSN

STAT · 6h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

· 2d · on MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

FDA’s new approach to covid vaccines could have been way worse

Older adults can continue getting covid boosters, but not everyone who wants them can.

· 2d

· 1d

FDA panel recommends keeping COVID shots targeted to same strain as last year

Alaska Dispatch News · 12h

Opinion: The FDA’s new covid vaccine policy is clear as mud

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 7h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 23h

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

4hon MSN

The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine access, and medical ethics.

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat

1don MSN

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter

1don MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.

2don MSN

Moderna withdraws application for COVID-flu combination vaccine

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration.

Explore more

Food and Drug Administration